(ZYME) – Mergers and Acquisitions
-
Zymeworks (ZYME) Announces Expiration of Hart-Scott-Rodino Waiting Period for Zanidatamab License Agreement with Jazz Pharmaceuticals
-
Zymeworks’ (ZYME) Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal
-
-
-
-
Back to ZYME Stock Lookup